UIM6:F:F-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 508.48

Change

+23.29 (+4.80)%

Market Cap

USD 0.59B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+19.06 (+3.52%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.51 (+2.95%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.65 (+2.95%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.45 (+2.92%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.43%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+4.62 (+4.86%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 45.80B
0ZC:F Zscaler Inc

+10.00 (+4.83%)

USD 37.92B
BSND:F Danone SA

-0.30 (-2.07%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+4.76 (+3.86%)

USD 24.77B

ETFs Containing UIM6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.88% 17% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.88% 17% F 37% F
Trailing 12 Months  
Capital Gain 9.24% 75% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.24% 72% C 59% D-
Trailing 5 Years  
Capital Gain 98.93% 84% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 98.93% 84% B 58% F
Average Annual (5 Year Horizon)  
Capital Gain 15.38% 88% B+ 76% C+
Dividend Return 15.38% 85% B 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.01% 38% F 80% B-
Risk Adjusted Return 102.45% 92% A 94% A
Market Capitalization 0.59B 64% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.